New Medicine for Bipolar Disorder

This episode of New Medicine focus on mood disorders, specifically bipolar disorder, a condition in which a person's mood can alternate from low to high. Our guest is the internationally renowned psychiatrist and psychopharmacologist, Ronald R. Fieve, M.D., the pioneer in the use of lithium for the treatment of bipolar illness in America. A graduate of Harvard Medical School, extensively trained in psychopharmacology and psychiatry, he served his residencies at New York Hospital in internal medicine, and in psychiatry at Columbia Presbyterian Medical Center and the New York State Psychiatric Institute in New York City. Dr. Fieve is professor of clinical psychiatry at Columbia University, chief of research at the department of lithium studies at the New York State Psychiatric Institute, founder of the former Foundation for Depression and Manic Depression Inc. and executive director of the new Foundation for Mood Disorders. Dr. Fieve is the author of the best-selling book, Moodswing: Dr. Fieve on Depression (Bantam, 1997), Prozac: Questions and Answers for Patients, Families and Physicians (Avon, 1994), Second Opinion on Lithium Therapy for Depression and Manic Depression (1996), Bipolar II (Rodale, 2006) and Bipolar Breakthrough (Rodale, 2009). To find clinical trials for Bipolar Disorder visit www.clinicaltrials.gov. To find clinical trials being conducted at Clinilabs clinical research unit in New York, or to learn more about projects under management worldwide, visit www.clinilabs.com.